Product Information
TOLTERODINE TART ER 4 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2312 per EA under NDC 00093716405. Its NADAC has been published 495 times since Apr 12, 2017.
FDA first approved this application on Nov 22, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093716405
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOLTERODINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA079141FDA Approved
11/22/2016
TE Code
AB
On Market Since
3/20/2017
Pharmacological Classes
Price Statistics
The NADAC for TOLTERODINE TART ER 4 MG CAP has been published 495 times since Apr 12, 2017, and over the history we have for it it has declined 92.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2312 per EA |
|---|---|
| All-time high | $3.1597 (Apr 12, 2017) |
| All-time low | $0.2285 (Apr 22, 2026) |
| 52-week high | $0.3063 |
| 52-week low | $0.2285 |
| Median price | $1.1454 |
| Average price | $1.1182 |
| Largest weekly change | +27.2% (Jun 19, 2024) |
| Weeks tracked | 495 |
| Tracking since | Apr 12, 2017 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tolterodine Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOLTERODINE TART ER 4 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for TOLTERODINE TART ER 4 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.2312 per EA (NDC 00093716405), effective Sep 30, 2026.
How has the price of TOLTERODINE TART ER 4 MG CAP changed over time?
Over the history we have for it, the NADAC for TOLTERODINE TART ER 4 MG CAP has declined 92.7%. It has been tracked across 495 weekly CMS publications since Apr 12, 2017.
What are the highest and lowest recorded NADAC prices for TOLTERODINE TART ER 4 MG CAP?
Since Apr 12, 2017, the NADAC for TOLTERODINE TART ER 4 MG CAP has ranged from a low of $0.2285 (Apr 22, 2026) to a high of $3.1597 (Apr 12, 2017), with a median of $1.1454 per EA.
Are there cheaper alternatives to TOLTERODINE TART ER 4 MG CAP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOLTERODINE TART ER 4 MG CAP, is $0.2304 per EA — about 0% below TOLTERODINE TART ER 4 MG CAP.
Who manufactures TOLTERODINE TART ER 4 MG CAP?
TOLTERODINE TART ER 4 MG CAP (NDC 00093716405) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.